Abstract
INTRODUCION
Oroxylumindicum (L.) Vent (O. indicum) mainly grows in India, Japan, China, Sri Lanka and Malaysia and has been used for centuries as a traditional remedy for respiratory diseases, diabetes, diarrhea, cancer, ulcer, dysentery, wound healing, enlarged spleen, jaundice, scabies and other skin diseases 1 in these countries. Furthermore, O. indicumis one of the ingredients used in Wang Laoji, a very popular herbal tea which is supposed to have health care function in China. Many in vivo and in vitro studies have indicated that O. indicum has various pharmacological effects of anti-inflammation, antiulcer, hepato-protection, anticancer, antioxidant, anti-proliferation, arthritic improvement, antimicrobial, and so on. [2] [3] [4] Various parts of the plant such asits root bark, stem bark, leaves, fruits and seeds, have been used in folk medicine, modern medicine or relative healthy food. In India, Bangladesh and Thailand, the leaves were mainly used for medicine, while in China, the seeds were primarily used. [5] [6] [7] Flavonoids and their glycosides compounds are the main effective components of O. indicum. Hydroxyl phenyl ethyl alcohol, cyclic alcohol compounds, pterocarpan volatile oil, organic acids and other substances are its secondary metabolic products. Nowadays, more than 30 flavonoids including baicalein, chrysin, oroxinA, oroxin B, tetuin, coarse wool ragweed element, 5-hydroxy-dimethyl oxygen radicals and chrysin-7-O-beta pyrangalacturonide were isolated from different parts of O. indicum. 1, 8, 9 Baicalein and chrysin are reported to have various pharmacodynamic activities such as anti-inflammation, anti-ulcer, antioxidation, antibacteria, antifungus and antivirus, hepatoprotection and immunomodulation. 10 The main flavonoidbaicalein was generally well tolerated in a single doseas seen in arandomized, double-blind, single-dose trial of oral baicalein (100-2800 mg) in 72 healthy adults, 11 and no toxicity was shown in animal experiments for baicalein administration. But there is no toxicity test performed for long-time administration of O. indicum extract. Considering O. indicum is a widely consumed herbal medicine and commonly used in health care products in China, India and other Asian countries, the safety data were required for its application.
MATERIALS AND METHODS

Preparation of test article
The seed of O. indicum was harvested from Yunnan province, China. The species was identified by Prof. Bin Yang and the voucher specimen was preserved at the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences. The dried seed powder of O. indicum (25 kg) was extracted two times with 70%ethyl alcohol (EtOH) (400 L × 2 h, 250 L × 2 h). The extract collected,concentrated and dried yielding 3 kg extract (12% of the raw herb).The dried extract powder was dissolved with 0.1% polysorbate 80 solution and diluted to concentrations of 5.4, 22.5, 45.0 mg/mL for the administration doses of 54, 225, 450 mg/kg (equal to 0.45, 1.88 and 3.75 g crude herb/kg, respectively)at the administration volume of 10 mL/kg.
Analysis of sample
The O. indicum extract (OIE) batch used in this study was analyzed before administration. Reference substances Baicalein (> 98.0% ) was purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China), and Chrysin (S36906-387) was purchased from Sigma-Aldrich Company (St. Louis, MO, USA). The standard solution was prepared by dissolving each reference substance in methanol at the concentrations of 81.50 μg/ mL (baicalein) and 34.00 μg/mL (chrysin). OIE (6.13 mg) was weighed and dissolvedin 10 mL methanol, ultrasonic processing for 30 min. After cooling down, the extracted solution was filtered through a 0.22 mm filter before analysis. Experiments were performed on a Waters Alliance system, equipped with a binary pump, an autosampler, a column oven and a Waters 2996 DAD. An Agilent Zorbax C18 column (5 μm, 4.6 mm × 250 mm) (Agilent Technologies, Palo Alto, CA, USA) was used and column temperature was controlled at 30℃. For the analysis of O. indicum, a mixture solution ofwater-85% phosphoric acid (99.7∶ 0.3, v/v) (solvent A), CH3OH (solvent B) and CH3CN (solvent C) was used as mobile phase. The mobile phase was applied in the following gradient elution: 100-85% A, 0-15% C at 0-10 min; 85-76% A, 0-9% B, 15-15% C at 10-27 min; 76-63% A, 9-22% B, 15-15% C at 27-50 min, and 63-8% A, 22-17% B, 15-75% C at 50-60 min. The flow rate was 1.0 mL/min. The typical HPLC profiles of the sample solutions extracted from the seed of O. indicum were shown in Figure 1 . The contents of baicalein and chrysin were 6.99% and 1.51% in OIE respectively.
Animals and husbandry
The experiments were conducted in accordance with the Guide for Care and Use of Laboratory Animals issued by the National Institutes of Health. The Institutional Animal Care and Use Committee of the China Academy of Chinese Medical Sciences approved the procedure. The animals were specific pathogen free Wistar rats with both sexes at the initial age of 5 weeks, 60-90 g, purchased from Charles River/Vital River Co., Ltd., Beijing, China [Licence No. SCXK (Jing) 2012-0001]. The animals were kept in Medical Experimental Animal Center of China Academy of Chinese Medical Sciences. Husbandry was standardized in accordance with State Standard for Animal Administration of the People's Republic of China, with 12 h of electrical lighting and 12 h of dark daily, room temperature (20-22) ℃ , relative humidity of 40%-70% , air change about 15 times per hour. Every 5 rats were bred in one cage, receiving quantitative fixed-formula granular feed (purchased from Beijing KeaoXieli Feed Co., Ltd., Beijing, China) and filtrated tap water ad libitum. All rats were allowed to acclimatize to housing conditions one week prior to start of the treatment.
Grouping and administration
The rats were randomly assigned to four groups according body weight and random number table method: control group and OIE 54, 225, 450 mg/kg groups, 20 male and 20 female rats for each group. The rats of control group were given 0.1% polysorbate 80 solution by gavage, while rats of OIE treatment groups were respectively given with corresponding concentration of OIEs which dissolved in 0.1% polysorbate 80 solution. The rats were weighed once a week and the dosing volume of each rat was adjusted according to the most recent body weights. Five males and five female rats in each group were scarified respectively at the end of 13 weeks and 26 weeks of administration. After administration for 26 weeks, the remaining rats in each group were allowed to recover for 4 weeks without administration and then were sacrificed at the end of recovery. All rats sacrificed at each stage were performed comprehensive examination as following.
General conditions, body weight and food consumption General conditions of rats such as behavior, gait and general activity, appearance, hair luster, stool and urine secretion were observed before and after OIE's dosing each day. The body weights of all rats were measured without fasting once a week during experiment. On the day of autopsy, each rat was weighed after fasting for 16-18 h for calculation of the relative organ/body weights. The amounts of supplied and residual diet were weighed once a week in order to calculate the food consumption.
Urinalysis
Animals were placed individually in the metabolic cages with water available, but free of food. The urine was collected for 16 h, and then the water intake and urine volume were measured. The parameters including urine glucose (GLU), ketone body (KET), bilirubin (BIL), pH, specific gravity (SG), occult blood (BLO), protein (PRO), urobilinogen (URO), leukocytes (Leu) were analyzed by using urinary test papers in the Urine Analyzer (SIEMENS CLINITEK status, Munich, Germany).
Hematology and serum biochemical analysis After 13, 26 weeks of administration, the animals were fasted overnight and then anesthetized by sodium Phenobarbital (30 mg/kg i.p). The blood sample of each rat was taken from abdominal aorta, and the serum and plasma were isolated for analyses of the hematology, coagulation and biochemistry parameters. An automatic blood cell analyzer (ADVIA2120 made in Siemens Co., Ltd., Munich, Germany) was used to test following parameters of hematology: Red blood cell count (RBC), white blood cell count (WBC), hemoglobin (HGB), haematocrit (HCT), blood platelet number (PLT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), leukocyte differential count and reticulocyte. Coagulation function indexes, including prothrombin time (PT) and activated partial thromboplastin time (APTT) were determined by using a blood coagulation meter (C2000-4, Beijing Precil Instrument Co., Ltd. Beijing, China). The levels of biochemical indicators such as serum total protein (TP),albumin (ALB), aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), γ-glutamyl-transferase (γ-GT), creatinekinase (CK), blood urea nitrogen(BUN), creatinine (CRE), glucose (GLU), total bilirubin (TBIL), total cholesterol (T-CHO), triglyceride (TG), calcium (Ca), phosphorus (P) were detected by automatic biochemistry analyzer (TOSHIBA 40FR, Tokyo, Japan). The serum electrolytes Na 
Autopsy and histomorphological observation
Organs including brain, pituitary, salivary gland, thymus, lung with bronchi, heart, liver, spleen, kidney, stomach, adrenal gland, testicle, prostate, seminal vesicle, ovary, uterus were removed and weighed, then the relative organ weight were calculated as following: rela- tive Organ Weight (% ) = [organ weight (g)/ body weight (g)] × 100. All removed organs were fixed by 10% formalin solution, paraffin embedded, sliced and HE (Haematoxylin & Eosin) stained. Histomorphological observation of slides under microscopes were firstly performed in control group and OIE 450 mg/kg group, if any abnormal changes of histomorphology related to treatment were observed, the histopathologic examination should be taken in the other two groups as well.
Statistical analysis
The parameters including body weight, food consumption, organ weight, urology, hematology and blood biochemistry were expressed as the mean ± standard deviation and analyzed by using SPSS16.0 (SPSS Inc. Released 2007. SPSS for Windows, Version 16.0. Chicago, IL, USA). Differences between control group and administration groups were analyzed by one-way analysis of variance (ANOVA) for quantitative data. The urinary qualitative data and histopathological changes were analyzed by Kruskal-Wallis test and Mann-Whitney's U-test. The differences were considered to be statistically significant when P < 0.05.
RESULTS
General conditions, body weight and food consumption
In all treatment groups, neither rats died nor abnormality shown during the whole experiment. As for the body weights and food consumptions, there was no significant difference between all OIE treatment groups and control group (Figures 2, 3 ).
Urinary analysis
No significant differences were found in the amount of urine between all treatment groups and the control group. At the end of administration for 26 weeks, PH value of male rats in OIE 225 mg/kg group was lower (P < 0.05, compared with control group).After recovery for 4 weeks, the urinary leukocytes of male rats and the blood occult value in female rats in OIE 450 mg/ kg group were higher than that in control group (P < 0.05) (data not shown). However, these changes of the above parameters were considered as false positive results interfered by the color of OIE metabolites in the urine, so they had no obvious toxicological significance. Other urinary parameters showed no obvious changes during the whole experiment.
Hematology and coagulation indexes
At the end of 13 weeks, male rats showed a significant decrease in RBC, HGB and HCT values at all three doses (P < 0.01, P < 0.05, P < 0.01). In addition, WBC in 54 mg/kg group (P < 0.05) and PT in 450 mg/kg group decreased in male rats, too (P < 0.01). PT of female rats in OIE 54 and 225 mg/kg groups was longer than that in the control group (P < 0.001, P < 0.01). The percentage of reticulocytes was obviously increased in both sexes of high dose group (P < 0.05) ( Table 1) . At the end of 26 weeks, the value of neutrophilic granulocyterate (Gr%) and monocyte rate (Mo% ) decreased (P < 0.001), and lymphocyterate (Ly%) increased significantly in male rats in three treatment groups (P < 0.001). WBC, RBC, HGB and HCT were lower and reticulocyte was higher obviously in 450mg/kg group in female rats (P < 0.01, compared to control group) ( Table 2) . After recovery for 4 weeks, Gr, Ly, PT and APTT were significantly increased in female rats of OIE225 mg/kg group (P < 0.05) (Table  3) . However, the above changes are not considered to be toxicological because the values of these parameters are within the normal physiological range of the rats Table 1 Hematological data of male and female rats orally administered with OIE for 13 weeks ( used in this experiment. Other hematology parameters showed no obvious changes during the whole experiment.
Biochemistry
As shown in Tables 4, 5 , 6, at the end of 13 weeks, male rats showed a decrease in serum CK and K + values at doses of 225 and 450 mg/kg (P < 0.05),and female rats showed an increase in ALT and BUN level at dose of 54 mg/kg (P < 0.01, P < 0.05). At the end of 26 weeks, serum levels of GLU and TG in male rats of 450 mg/kg group increased significantly (P < 0.01, P < 0.05), while ALP in male rats of 225 mg/kg group and ALB, AST, CK, CRE, TP and Na + levels in females of 450 mg/kg group were obviously decreased (P < 0.05). In addition, the level of BUN in 225 mg/kg OIE group was increased (P < 0.01). After recovery for 4 weeks, male rats showed decrease effects in CHO at dose of 54 mg/kg and GLU at dose of 450 mg/kg (P < 0.05, P < 0.01). In female rats, CK and BUN levels of 54 and 450 mg/kg groups decreased significantly (P < 0.01), and GLU of 450 mg/kg group increased obviously (P < 0.01). It should be noted that these parameter changes are all within the normal physiological range of the rat and are therefore not considered toxicologically significant. Other biochemical parameters showed no obvious changes throughout the whole experiment.
Relative organ weight
During the whole administration and recovery periods, the relative organ weights (ROW) of various main organs in all treatment groups had no significant changes compared with control group except that the female liver ROW increased at 450 mg/kg dose level and kidney ROW decreased at 54 mg/kg dose levelat the end of 26 weeks, and the male kidney ROW increased at 450 mg/kg dose level (Tables 7-9 ).
Autopsy and macroscopic examination
No obvious abnormal findings such as swelling, effusion, capillary hemorrhage and conglutination were observed in all OIE groups by autopsy. No treatment-related findings were observed in all treatment groups under the microscopic examination during the treatment and recovery periods（Figure 4).
DISCUSSION
This study examined the safety of oral administration of O. indicum ethanol extracts in rats for up to 26 weeks, in order to provide a scientific basis for the wider use of this herbal in the future. The results of this study indicate that during the whole experiment, no significant treatment-related toxicity was observed at all three dose levels by judgment of animal's general conditions, body weight, feed consumption, urology, hematology, blood biochemistry and histomorphology. Compared with the control group, HGB, HCT, PT, AST, ALP, GLU, BUN, K+and other hematological and blood biochemical indicators had slight but statistically significant changes. However, the levels of those parameters were still in the normal physiological ranges of the rats used in this study. In addition, no findings associated with these changes were observed in histopathological examinations. Therefore, it is considered that the observed changes in hematology and serum biochemistry are not OIE-induced toxic effects. Reticulocytes are immature red blood cells, which develop and mature in the bone marrow and then circulate for about one day in the blood stream before developing into mature red blood cells. The number of reticulocytes is a good indicator of bone marrow activity. If there is a problem of blood red cell loss, such as anemia, the bone marrow will produce more reticulocytes, so there is often a markedly high number and percentage of reticulocytes. 12, 13 In this study, reticulocytes of male and female rats slightly increased in 450 mg/kg dose group at the end of 13 weeks and female rats mildly increased in 225 and 450 mg/kg groups at the end of 26 weeks. Given the tendency of RBC, HGB, and reticulocytes to decrease and increase after 13 and 26 weeks of administration of high-and/or intermediate-dose OIE, it is not possible to rule out the potential effect of this extract on red blood cells. Therefore, we suggest that if the ethanol extract of O. indicum is used for a long time, hematology, especially anemia, should be monitored regularly.
In conclusion, the ethanol extract of O. indicum was orally administered orally to rats at a dose of up to 450 mg/kg for 26 weeks, and the rats were well tolerated without significant toxicity. And the extract dose reached 75 times the clinical dose (the maximum clinical O. indicum dose for adults: 0.05 g crude drug/kg). Table 4 Serum biochemical data of male and female rats orally administered with OIE for 13 weeks ( Table 9 Relative organ weights of males and female rats 4 weeks' recovery (%, x ± s) Notes: for 5 rats per sex in each group. Significantly different from control by Dunnett's test: 
